Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA
Wednesday, 8 March 2023 ()
BEVERLY, Mass. and BANGALORE, India--(BUSINESS WIRE)-- #VIE--Akston ends vaccine partnership with Stelis, reclaiming all rights to AKS-452, a protein subunit COVID vaccine, to continue to advance Booster EUA.
|
||||
You Might Like |
||||
